Emma Allott

Personal profile

Research Interests

Dr Emma Allott's research integrates epidemiologic methods and design with molecular tumour profiling to identify mechanisms linking dietary and lifestyle factors with cancer risk and progression. She directs omics and immunohistochemistry analyses of archival tissue specimens to generate molecular epidemiology resources, and leads a research program focused on the role of statin use, high serum cholesterol and dysregulated tumour lipid metabolism in prostate cancer progression. In addition, she collaborates with a number of existing studies, both in the US and Ireland, integrating immunohistochemistry and genome wide expression profiling with clinical and epidemiologic data in large cohorts of breast and prostate cancer.

Fingerprint Dive into the research topics where Emma Allott is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

35 Similar Profiles

Prostatic Neoplasms Medicine & Life Sciences

Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences

Breast Neoplasms Medicine & Life Sciences

Neoplasms Medicine & Life Sciences

Cholesterol Medicine & Life Sciences

Obesity Medicine & Life Sciences

Cancer Care Facilities Medicine & Life Sciences

Prostate Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2019

43 Article
6 Review article
4 Comment/debate
2 Chapter (peer-reviewed)
1 More
- 1 Editorial

Bimodal age distribution at diagnosis in breast cancer persists across molecular and genomic classifications

Allott, E., Shan, Y., Chen, M., Sun, X., Garcia-Recio, S., Kirk, E. L., Olshan, A. F., Geradts, J., Earp, H. S., Earp, H. S., Carey, L. A., Perou, C. M., Pfeiffer, R. M., . Anderson, W. F. & Troester, M. A., 18 Sep 2019, In : Breast Cancer Research and Treatment.

Research output: Contribution to journal › Article

Open Access

File

Age Distribution

Breast Neoplasms

RNA

Age of Onset

Neoplasms

Borderline estrogen receptor-positive breast cancers in black and white women

Benefield, H. C., Allott, E. H., Reeder-Hayes, K. E., Perou, C. M., Carey, L. A., Geradts, J., Sun, X., Calhoun, B. C. & Troester, M. A., 19 Nov 2019, In : Journal of the National Cancer Institute.

Research output: Contribution to journal › Article

Estrogen Receptors

Breast Neoplasms

hydroquinone

Neoplasms

Therapeutics

Evidence for etiologic subtypes of breast cancer in the Carolina Breast Cancer Study

Benefield, H. C., Zabor, E. C., Shan, Y., Allott, E. H., Begg, C. B. & Troester, M. A., 08 Aug 2019, In : Cancer Epidemiology Biomarkers & Prevention.

Research output: Contribution to journal › Article

Estrogen Receptors

Breast Neoplasms

Biomarkers

Incidence

Progesterone Receptors

Intratumoral sterol-27-hydroxylase (CYP27A1) expression in relation to cholesterol synthesis and vitamin D signaling and its association with lethal prostate cancer

Khan, N. A., Stopsack, K., Allott, E. H., Gerke, T., Giovannucci, E. L., Mucci, L. A. & Kantoff, P. W., Jun 2019, In : Cancer Epidemiology Biomarkers & Prevention. 28, 6, p. 1052-1058 7 p.

Research output: Contribution to journal › Article

Cholestanetriol 26-Monooxygenase

Vitamin D

Prostatic Neoplasms

Cholesterol

4 alpha-glucanotransferase

Reply by Authors

Dambal, S., Howard, L. E., Allott, E. H., Aronson, W. J., Kane, C. J., Amling, C. L., Cooperberg, M. R., Terris, M. K. & Freedland, S. J., 14 Oct 2019, In : Journal of Urology.

Research output: Contribution to journal › Comment/debate